Zhanna Belaya
Overview
Explore the profile of Zhanna Belaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belaya Z, Przhiyalkovskaya E, Mamedova E, Gronskaia S, Tarbaeva N, Sharova M, et al.
J Clin Densitom
. 2025 Jan;
28(1):101554.
PMID: 39778461
Bone Health ECHO (Extension of Community Healthcare Outcomes) is a growing family of online educational programs. Its mission is to enhance delivery of best practice skeletal healthcare worldwide. Each program...
2.
Belaya Z, Gronskaia S, Golounina O, Degtyarev M, Tarbaeva N, Rozhinskaya L, et al.
J Clin Densitom
. 2025 Jan;
28(1):101552.
PMID: 39778460
Bone Health ECHO (Extension of Community Healthcare Outcomes) is a virtual community of practice that has been connecting healthcare professionals online once weekly for the past 10 years. A key...
3.
Pludowski P, Marcinowska-Suchowierska E, Togizbayev G, Belaya Z, Grant W, Pilz S, et al.
Nutrients
. 2024 Aug;
16(15).
PMID: 39125420
Daily vitamin D supplementation using higher than normal dosing (up to the upper limit value) and intermittent (once or twice per week) dosing were studied in patients with increased risk...
4.
Gadelha M, Snyder P, Witek P, Bex M, Belaya Z, Turcu A, et al.
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1236465.
PMID: 37680892
Objective: To evaluate the long-term efficacy and safety of osilodrostat in patients with Cushing's disease. Methods: The multicenter, 48-week, Phase III LINC 4 clinical trial had an optional extension period...
5.
Gronskaya S, Belaya Z, Rozhinskaya L, Mamedova E, Vorontsova M, Solodovnikov A, et al.
Endocrine
. 2023 May;
81(2):368-378.
PMID: 37133642
Purpose: We aimed to assess the efficacy and safety of denosumab in postmenopausal women with primary hyperparathyroidism (PHPT)-related osteoporosis and chronic kidney disease (CKD). Methods: Women over 50 years of...
6.
Belaya Z, Rozhinskaya L, Dedov I, Drapkina O, Fadeev V, Golounina O, et al.
Osteoporos Int
. 2023 Jan;
34(3):429-447.
PMID: 36651943
Purpose: To summarize key statements of the Russian clinical practice guidelines for the diagnosis and treatment of osteoporosis. Methods: The Russian clinical guidelines on the diagnosis and treatment of osteoporosis...
7.
Minisola S, Arnold A, Belaya Z, Brandi M, Clarke B, Hannan F, et al.
J Bone Miner Res
. 2022 Oct;
37(11):2315-2329.
PMID: 36245271
In this narrative review, we present data gathered over four decades (1980-2020) on the epidemiology, pathophysiology and genetics of primary hyperparathyroidism (PHPT). PHPT is typically a disease of postmenopausal women,...
8.
Fleseriu M, Newell-Price J, Pivonello R, Shimatsu A, Auchus R, Scaroni C, et al.
Eur J Endocrinol
. 2022 Aug;
187(4):531-541.
PMID: 35980235
Objective: To investigate the long-term efficacy and tolerability of osilodrostat, a potent oral 11β-hydroxylase inhibitor, for treating Cushing's disease (CD). Design/methods: A total of 137 adults with CD and mean...
9.
Belaya Z, Melnichenko G, Golounina O, Tsoriev T, Rozhinskaya L, Dubovitskaya T, et al.
Osteoporos Int
. 2022 May;
33(9):2035-2040.
PMID: 35593943
Introduction: Bone Health TeleECHO (Extension for Community Healthcare Outcomes) Moscow is the first Russian-speaking ECHO program, modeled after Bone Health TeleECHO at the University of New Mexico, USA. The bone...
10.
Pludowski P, Takacs I, Boyanov M, Belaya Z, Diaconu C, Mokhort T, et al.
Nutrients
. 2022 Apr;
14(7).
PMID: 35406098
Vitamin D deficiency has a high worldwide prevalence, but actions to improve this public health problem are challenged by the heterogeneity of nutritional and clinical vitamin D guidelines, with respect...